Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October-2023 Volume 26 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2023 Volume 26 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer

  • Authors:
    • Xingxing Yang
    • Biao Yu
    • Chuanying Xi
    • Chao Song
    • Rui Yang
    • Wei Wang
    • Xin Wang
    • Xuhan Zhang
    • Chuanlin Feng
    • Xinyu Wang
    • Guofeng Cheng
    • Yansong Chen
    • Yong Zhu
  • View Affiliations / Copyright

    Affiliations: School of Biological and Food Engineering, Hefei Normal University, Hefei, Anhui 230601, P.R. China, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, P.R. China, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, P.R. China
    Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 453
    |
    Published online on: September 4, 2023
       https://doi.org/10.3892/ol.2023.14040
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Due to the serious side effects of chemotherapy drugs against lung cancer, and the antitumor properties and high safety of magnetic fields, the present study combined moderate or ultra‑high intensity statics magnetic fields (SMFs) with platycodin D (PD) to explore the antitumor efficiency and biosafety. The antitumor effects of PD with or without moderate and ultra‑high SMFs on A549 cells bearing mice were compared. Mouse body weight, food/water intake, hematology routine, blood biochemistry, tumor weight and tissues hematoxylin and eosin (H&E) staining were examined. Behavior was measured using the elevated plus maze, open field and vital signs tests. The combined targets of PD and SMFs were detected using RNA‑sequencing (RNA‑seq). The results showed that the antitumor effect of 22 Tesla (T) SMF group was 3.6‑fold higher compared with that of the 2 mg/kg PD group (tumor growth inhibition=10.08%), while the antitumor effect of 150 mT SMF was only 1.56‑fold higher compared with that of PD. Although PD reduced the food intake, there was no significant difference in body weight, water intake or food consumption among PD and SMF groups. Behavioral results indicated that PD ameliorated dysphoria in mice, but SMFs reduced this effect. However, no significant abnormalities were found in routine blood, blood biochemistry test, H&E staining or organ index, except renal index which was reduced by PD with or without SMFs. RNA‑sequencing (RNA‑seq) demonstrated that SMFs and PD synergistically targeted the expression of genes associated with tumor growth, inflammation and neurological disease. The present study showed the antitumor efficacy and biosafety of moderate or ultra‑high SMF combined with PD, which exhibited only few side effects in the treatment of lung cancer, thus supporting further research for the clinical application of magnetic fields.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Sarracanie M, LaPierre CD, Salameh N, Waddington DEJ, Witzel T and Rosen MS: Low-cost high-performance MRI. Sci Rep. 5:151772015. View Article : Google Scholar : PubMed/NCBI

2 

Karpowicz J and Gryz K: The pattern of exposure to static magnetic field of nurses involved in activities related to contrast administration into patients diagnosed in 1.5 T MRI scanners. Electromagn Biol Med. 32:182–191. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Hoff MN, McKinney A IV, Shellock FG, Rassner U, Gilk T, Watson RE Jr, Greenberg TD, Froelich J and Kanal E: Safety considerations of 7-T MRI in clinical practice. Radiology. 292:509–518. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Thulborn K, Lui E, Guntin J, Jamil S, Sun Z, Claiborne TC and Atkinson IC: Quantitative sodium MRI of the human brain at 9.4 T provides assessment of tissue sodium concentration and cell volume fraction during normal aging. NMR Biomed. 29:137–143. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Ruhm L, Avdievich N, Ziegs T, Nagel AM, De Feyter HM, de Graaf RA and Henning A: Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution. Neuroimage. 244:1186392021. View Article : Google Scholar : PubMed/NCBI

6 

Vaughan T, DelaBarre L, Snyder C, Tian J, Akgun C, Shrivastava D, Liu W, Olson C, Adriany G, Strupp J, et al: 9.4T human MRI: Preliminary results. Magn Reson Med. 56:1274–1282. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Nagel AM, Umathum R, Rösler MB, Ladd ME, Litvak I, Gor'kov PL, Brey WW and Schepkin VD: (39) K and (23) Na relaxation times and MRI of rat head at 21.1 T. NMR Biomed. 29:759–766. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Schepkin VD, Bejarano FC, Morgan T, Gower-Winter S, Ozambela M Jr and Levenson CW: In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T. Magn Reson Med. 67:1159–1166. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Yilmaz S: The safety of high-field MRI? Int J Occup Environ Med. 5:63–64. 2014.PubMed/NCBI

10 

Tian X, Wang D, Feng S, Zhang L, Ji X, Wang Z, Lu Q, Xi C, Pi L and Zhang X: Effects of 3.5–23.0 T static magnetic fields on mice: A safety study. Neuroimage. 199:273–280. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Franco J: Magnetic resonance imaging safety. Radiol Technol. 91:343–356. 2020.PubMed/NCBI

12 

Yang X, Song C, Zhang L, Wang J, Yu X, Yu B, Zablotskii V and Zhang X: An upward 9.4 T static magnetic field inhibits DNA synthesis and increases ROS-P53 to suppress lung cancer growth. Transl Oncol. 14:1011032021. View Article : Google Scholar : PubMed/NCBI

13 

Tkáč I, Benneyworth MA, Nichols-Meade T, Steuer EL, Larson SN, Metzger GJ and Uğurbil K: Long-term behavioral effects observed in mice chronically exposed to static ultra-high magnetic fields. Magn Reson Med. 86:1544–1559. 2021. View Article : Google Scholar : PubMed/NCBI

14 

Khan MH, Huang X, Tian X, Ouyang C, Wang D, Feng S, Chen J, Xue T, Bao J and Zhang X: Short- and long-term effects of 3.5–23.0 Tesla ultra-high magnetic fields on mice behaviour. Eur Radiol. 32:5596–5605. 2022. View Article : Google Scholar : PubMed/NCBI

15 

Tian X, Lv Y, Fan Y, Wang Z, Yu B, Song C, Lu Q, Xi C, Pi L and Zhang X: Safety evaluation of mice exposed to 7.0–33.0 T high-static magnetic fields. J Magn Reson Imaging. 53:1872–1884. 2021. View Article : Google Scholar : PubMed/NCBI

16 

Tian X, Wang D, Zha M, Yang X, Ji X, Zhang L and zhang X: Magnetic field direction differentially impacts the growth of different cell types. Electromagn Biol Med. 37:114–125. 2018. View Article : Google Scholar : PubMed/NCBI

17 

Wang S, Luo J, Lv H, Zhang Z, Yang J, Dong D, Fang Y, Hu L, Liu M, Liao Z, et al: Safety of exposure to high static magnetic fields (2 T-12 T): A study on mice. Eur Radiol. 29:6029–6037. 2019. View Article : Google Scholar : PubMed/NCBI

18 

Lv Y, Fan Y, Tian X, Yu B, Song C, Feng C, Zhang L, Ji X, Zablotski V and Zhang X: The anti-depressive effects of ultra-high static magnetic field. J Magn Reson Imaging. 56:354–365. 2022. View Article : Google Scholar : PubMed/NCBI

19 

Tian X, Wang C, Yu B, Fan Y, Zhang L and Zhang X: 9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Eur J Nucl Med Mol Imaging. 50:314–327. 2023. View Article : Google Scholar : PubMed/NCBI

20 

Yu X, Ji X, Fan Y, Yu B, Wang X, Feng C, Zhang L, Song C and Zhang X: Static magnetic fields protect against cisplatin-induced kidney toxicity. Antioxidants (Basel). 12:732022. View Article : Google Scholar : PubMed/NCBI

21 

Begnini KR, Moura de Leon PM, Thurow H, Schultze E, Campos VF, Martins Rodrigues F, Borsuk S, Dellagostin OA, Savegnago L, Roesch-Ely M, et al: Brazilian red propolis induces apoptosis-like cell death and decreases migration potential in bladder cancer cells. Evid Based Complement Alternat Med. 2014:6398562014. View Article : Google Scholar : PubMed/NCBI

22 

Rahmani AH, Alzohairy MA, Khan MA and Aly SM: Therapeutic implications of black seed and its constituent thymoquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evid Based Complement Alternat Med. 2014:7246582014. View Article : Google Scholar : PubMed/NCBI

23 

Tada A, Kaneiwa Y, Shoji J and Shibata S: Studies on the saponins of the root of Platycodon grandiflorum A. De Candolle. I. Isolation and the structure of platycodin-D. Chem Pharm Bull (Tokyo). 23:2965–2972. 1975. View Article : Google Scholar : PubMed/NCBI

24 

Li W, Liu Y, Wang Z, Han Y, Tian YH, Zhang GS, Sun YS and Wang YP: Platycodin D isolated from the aerial parts of Platycodon grandiflorum protects alcohol-induced liver injury in mice. Food Funct. 6:1418–1427. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Lee WH, Gam CO, Ku SK and Choi SH: Single oral dose toxicity test of platycodin d, a saponin from platycodin radix in mice. Toxicol Res. 27:217–224. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Khan M, Maryam A, Zhang H, Mehmood T and Ma T: Killing cancer with platycodin D through multiple mechanisms. J Cell Mol Med. 20:389–402. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Chun J and Kim YS: Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chem Biol Interact. 205:212–221. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Zhou R, Lu Z, Liu K, Guo J, Liu J, Zhou Y, Yang J, Mi M and Xu H: Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo. Curr Cancer Drug Targets. 14:860–871. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Ye Y, Han X, Guo B, Sun Z and Liu S: Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines. Environ Toxicol Pharmacol. 36:115–124. View Article : Google Scholar : PubMed/NCBI

30 

Tang ZH, Li T, Gao HW, Sun W, Chen XP, Wang YT and Lu JJ: Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells. Chin Med. 9:162014. View Article : Google Scholar : PubMed/NCBI

31 

Yang X, Yu B, Song C, Feng C, Zhang J, Wang X, Cheng G, Yang R, Wang W and Zhu Y: The effect of long-term moderate static magnetic field exposure on adult female mice. Biology (Basel). 11:15852022.PubMed/NCBI

32 

Schwartz DJ, Conover MS, Hannan TJ and Hultgren SJ: Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog. 11:e10045992015. View Article : Google Scholar : PubMed/NCBI

33 

Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y and Ohyashiki K: Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer. 92:2399–2405. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Yu B, Song C, Feng CL, Zhang J, Wang Y, Zhu YM, Zhang L, Ji XM, Tian XF, Cheng GF, et al: Effects of gradient high-field static magnetic fields on diabetic mice. Zool Res. 44:249–258. 2023. View Article : Google Scholar : PubMed/NCBI

35 

Kim TW, Song IB, Lee HK, Lim JH, Cho ES, Son HY, Park SJ, Kim JW and Yun HI: Platycodin D, a triterpenoid sapoinin from Platycodon grandiflorum, ameliorates cisplatin-induced nephrotoxicity in mice. Food Chem Toxicol. 50:4254–4259. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Luo Y, Ji X, Liu J, Li Z, Wang W, Chen W, Wang J, Liu Q and Zhang X: Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol. Bioelectrochem. 109:31–40. 2016. View Article : Google Scholar

37 

Zhao L, Yu Z and Zhao B: Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells. Med Oncol. 36:912019. View Article : Google Scholar : PubMed/NCBI

38 

Moody TW, Leyton J, Chan D, Brenneman DC, Fridkin M, Gelber E, Levy A and Gozes I: VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells. Breast Cancer Res Treat. 68:55–64. 2001. View Article : Google Scholar : PubMed/NCBI

39 

Silverstein RL and Febbraio M: CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2:re32009. View Article : Google Scholar : PubMed/NCBI

40 

Guan F, Zhang T, Liu X, Han W, Lin H, Li L, Chen G and Li T: Evaluation of voltage-dependent calcium channel γ gene families identified several novel potential susceptible genes to schizophrenia. Sci Rep. 6:249142016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang X, Yu B, Xi C, Song C, Yang R, Wang W, Wang X, Zhang X, Feng C, Wang X, Wang X, et al: A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer. Oncol Lett 26: 453, 2023.
APA
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W. ... Zhu, Y. (2023). A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer. Oncology Letters, 26, 453. https://doi.org/10.3892/ol.2023.14040
MLA
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W., Wang, X., Zhang, X., Feng, C., Wang, X., Cheng, G., Chen, Y., Zhu, Y."A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer". Oncology Letters 26.4 (2023): 453.
Chicago
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W., Wang, X., Zhang, X., Feng, C., Wang, X., Cheng, G., Chen, Y., Zhu, Y."A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer". Oncology Letters 26, no. 4 (2023): 453. https://doi.org/10.3892/ol.2023.14040
Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Yu B, Xi C, Song C, Yang R, Wang W, Wang X, Zhang X, Feng C, Wang X, Wang X, et al: A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer. Oncol Lett 26: 453, 2023.
APA
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W. ... Zhu, Y. (2023). A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer. Oncology Letters, 26, 453. https://doi.org/10.3892/ol.2023.14040
MLA
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W., Wang, X., Zhang, X., Feng, C., Wang, X., Cheng, G., Chen, Y., Zhu, Y."A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer". Oncology Letters 26.4 (2023): 453.
Chicago
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W., Wang, X., Zhang, X., Feng, C., Wang, X., Cheng, G., Chen, Y., Zhu, Y."A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer". Oncology Letters 26, no. 4 (2023): 453. https://doi.org/10.3892/ol.2023.14040
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team